Table 2.
Comparisons between prevalence of the different metabolic abnormalities across the five small countries in Europe
| Prevalence | Cyprus | Iceland | Luxembourg | Malta | Montenegro |
|---|---|---|---|---|---|
| Type 2 diabetes | 10.4% (2005) | 6.72% (2005–2011) | 9.8% (2016–2018) | 10.4% (2014–2016) | 10.2% (2014) |
| Obesity (BMI > 30 kg/m2) | 25.5% (2008) | 26.6% (2017) | 19.2% (2016–2018) | 34.1% (2014–2016) | 25% (2016) |
| Impaired glucose tolerance | – | – | 25.6% (2013–2015) | – | – |
| Impaired fasting glucose | – | – | – | 24.3% (2014–2016) | – |
| Metabolic syndrome | – | – | 28.0% (2008–2009) | 26.3% (2014–2016) | – |
BMI Body mass index